Elisabeth von der Mark

Roche (Switzerland)

Papers

1

Total Citations

13

H-Index

1

About

Elisabeth von der Mark is a distinguished researcher in cardiovascular proteomics and lipoprotein biology, with a particular focus on the molecular characterization of plasma lipoproteins and their role in disease. Her major contribution lies in pioneering multidimensional profiling techniques that bridge analytical chemistry and clinical diagnostics. In her landmark 2011 work, cited 13 times, she developed a novel method combining size exclusion chromatography with reverse-phase protein arrays, enabling the simultaneous analysis of lipoprotein subclasses and their associated apolipoproteins. This approach provided unprecedented resolution of the complex protein cargo carried by different lipoprotein particles, offering new insights into cardiovascular disease mechanisms. Von der Mark’s work has been instrumental in advancing our understanding of how specific apolipoprotein profiles correlate with disease risk, moving beyond traditional lipid measurements. Her methodological innovations have been adopted by laboratories studying atherosclerosis and metabolic disorders, demonstrating her impact on both basic science and translational research. Through her careful characterization of lipoprotein-associated proteins, she has helped establish a more nuanced view of cardiovascular risk, where the composition of particles matters as much as their quantity.

Research Focus

Key Achievements

1
H-Index
1
Papers
13
Total Citations
13
Avg Citations/Paper
🏆 Most Cited Paper
Multidimensional profiling of plasma lipoproteins by size exclusion chromatography followed by reverse-phase protein arrays
13 citations · 2011
📈 Most Prolific Year: 2011 (1 Papers)
🤝 Key Collaborators: 9
🏛 Institutions: Roche (Switzerland)

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago